Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VK 2809

Next Previous
X
Search
Drug Profile

VK 2809

Alternative Names: MB-07811; VK-2809

Latest Information Update: 26 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Metabasis Therapeutics
  • Developer Duke University; Viking Therapeutics
  • Class Antihyperlipidaemics; Obesity therapies; Organophosphorus compounds; Small molecules
  • Mechanism of Action Thyroid hormone receptor beta agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Hypercholesterolaemia; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
  • No development reported Adrenoleucodystrophy; Glycogen storage disease type I

Most Recent Events

  • 26 Jul 2024 Viking Therapeutics plans end-of-phase II meeting in Non-alcoholic staetohepatitis in fourth quarter of 2024
  • 03 Jun 2024 Updated 52 weeks efficacy and adverse events data from a phase IIb VOYAGE trial in Non alcoholic steatohepatitis released by Viking therapeutics
  • 26 Jan 2024 Viking therapeutics completes a phase IIb VOYAGE trial in Non alcoholic steatoheapatitis in USA, Puerto Rico, Mexico, France, Belgium (PO) (NCT04173065)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top